Back to Search Start Over

Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progression.

Authors :
Yildirim Z
Baboo S
Hamid SM
Dogan AE
Tufanli O
Robichaud S
Emerton C
Diedrich JK
Vatandaslar H
Nikolos F
Gu Y
Iwawaki T
Tarling E
Ouimet M
Nelson DL
Yates JR 3rd
Walter P
Erbay E
Source :
EMBO molecular medicine [EMBO Mol Med] 2022 Apr 07; Vol. 14 (4), pp. e15344. Date of Electronic Publication: 2022 Feb 22.
Publication Year :
2022

Abstract

Fragile X Mental Retardation protein (FMRP), widely known for its role in hereditary intellectual disability, is an RNA-binding protein (RBP) that controls translation of select mRNAs. We discovered that endoplasmic reticulum (ER) stress induces phosphorylation of FMRP on a site that is known to enhance translation inhibition of FMRP-bound mRNAs. We show ER stress-induced activation of Inositol requiring enzyme-1 (IRE1), an ER-resident stress-sensing kinase/endoribonuclease, leads to FMRP phosphorylation and to suppression of macrophage cholesterol efflux and apoptotic cell clearance (efferocytosis). Conversely, FMRP deficiency and pharmacological inhibition of IRE1 kinase activity enhances cholesterol efflux and efferocytosis, reducing atherosclerosis in mice. Our results provide mechanistic insights into how ER stress-induced IRE1 kinase activity contributes to macrophage cholesterol homeostasis and suggests IRE1 inhibition as a promising new way to counteract atherosclerosis.<br /> (© 2022 The Authors. Published under the terms of the CC BY 4.0 license.)

Details

Language :
English
ISSN :
1757-4684
Volume :
14
Issue :
4
Database :
MEDLINE
Journal :
EMBO molecular medicine
Publication Type :
Academic Journal
Accession number :
35191199
Full Text :
https://doi.org/10.15252/emmm.202115344